Brokerages Expect Owens & Minor, Inc. (OMI) Will Post Earnings of $0.42 Per Share
Wall Street analysts forecast that Owens & Minor, Inc. (NYSE:OMI) will report $0.42 earnings per share (EPS) for the current quarter, Zacks reports. Four analysts have made estimates for Owens & Minor’s earnings. The lowest EPS estimate is $0.40 and the highest is $0.44. Owens & Minor posted earnings of $0.50 per share in the same quarter last year, which would suggest a negative year over year growth rate of 16%. The business is scheduled to announce its next quarterly earnings results on Tuesday, May 2nd.
According to Zacks, analysts expect that Owens & Minor will report full-year earnings of $1.80 per share for the current financial year, with EPS estimates ranging from $1.75 to $1.82. For the next fiscal year, analysts anticipate that the firm will post earnings of $2.09 per share, with EPS estimates ranging from $2.05 to $2.12. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of sell-side research analysts that cover Owens & Minor.
Owens & Minor (NYSE:OMI) last posted its earnings results on Tuesday, February 14th. The company reported $0.52 EPS for the quarter, topping the consensus estimate of $0.50 by $0.02. Owens & Minor had a net margin of 1.16% and a return on equity of 13.08%. The firm earned $2.37 billion during the quarter, compared to analysts’ expectations of $2.38 billion. During the same quarter in the prior year, the firm earned $0.56 EPS. Owens & Minor’s quarterly revenue was down 4.8% on a year-over-year basis.
This article was originally published by and is the sole property of American Banking News. If you happen to be reading this article on another website, it was stolen and illegally republished in violation of U.S. and International copyright law. The original version of this story can be read at https://www.americanbankingnews.com/2017/04/20/brokerages-expect-owens-minor-inc-omi-will-post-earnings-of-0-42-per-share.html
Several brokerages have recently commented on OMI. Zacks Investment Research cut shares of Owens & Minor from a “hold” rating to a “sell” rating in a research report on Wednesday, January 4th. Jefferies Group LLC set a $36.00 price target on shares of Owens & Minor and gave the stock a “hold” rating in a research report on Thursday, March 16th. Three research analysts have rated the stock with a sell rating and two have given a hold rating to the stock. The company has an average rating of “Sell” and a consensus price target of $33.33.
Owens & Minor (NYSE:OMI) opened at 33.41 on Thursday. The firm has a 50-day moving average of $34.76 and a 200 day moving average of $34.68. Owens & Minor has a 52-week low of $30.43 and a 52-week high of $38.47. The company has a market cap of $2.04 billion, a PE ratio of 18.98 and a beta of 0.97.
The firm also recently declared a quarterly dividend, which was paid on Friday, March 31st. Stockholders of record on Wednesday, March 15th were given a dividend of $0.2575 per share. This is a boost from Owens & Minor’s previous quarterly dividend of $0.23. The ex-dividend date of this dividend was Monday, March 13th. This represents a $1.03 annualized dividend and a dividend yield of 3.08%. Owens & Minor’s payout ratio is currently 55.74%.
TRADEMARK VIOLATION NOTICE: “Brokerages Expect Owens & Minor, Inc. (OMI) Will Post Earnings of $0.42 Per Share” was first posted by American Banking News and is owned by of American Banking News. If you are reading this article on another publication, it was illegally copied and reposted in violation of US & international copyright laws. The original version of this article can be viewed at https://www.americanbankingnews.com/2017/04/20/brokerages-expect-owens-minor-inc-omi-will-post-earnings-of-0-42-per-share.html.
In other news, Director Craig R. Smith sold 20,000 shares of Owens & Minor stock in a transaction that occurred on Monday, January 23rd. The shares were sold at an average price of $35.81, for a total transaction of $716,200.00. Following the completion of the sale, the director now owns 49,732 shares in the company, valued at approximately $1,780,902.92. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, SVP Charles C. Colpo sold 8,802 shares of Owens & Minor stock in a transaction that occurred on Tuesday, February 28th. The stock was sold at an average price of $36.04, for a total transaction of $317,224.08. Following the sale, the senior vice president now owns 38,705 shares of the company’s stock, valued at approximately $1,394,928.20. The disclosure for this sale can be found here. In the last quarter, insiders have sold 49,202 shares of company stock valued at $1,723,224. 1.72% of the stock is owned by corporate insiders.
Large investors have recently modified their holdings of the company. Stratos Wealth Partners LTD. purchased a new position in Owens & Minor during the third quarter valued at $529,000. Argentus Capital Management LLC raised its position in Owens & Minor by 10.5% in the third quarter. Argentus Capital Management LLC now owns 12,324 shares of the company’s stock valued at $428,000 after buying an additional 1,171 shares during the last quarter. Isthmus Partners LLC raised its position in Owens & Minor by 3.2% in the third quarter. Isthmus Partners LLC now owns 16,549 shares of the company’s stock valued at $554,000 after buying an additional 514 shares during the last quarter. Peregrine Capital Management LLC purchased a new position in Owens & Minor during the third quarter valued at $7,151,000. Finally, Donald L. Hagan LLC raised its position in Owens & Minor by 9.3% in the third quarter. Donald L. Hagan LLC now owns 28,002 shares of the company’s stock valued at $973,000 after buying an additional 2,371 shares during the last quarter. Institutional investors own 91.96% of the company’s stock.
About Owens & Minor
Owens & Minor, Inc is a healthcare services company that connects the world of medical products to the point of care. The Company provides supply chain assistance to the providers of healthcare services and the manufacturers of healthcare products, supplies and devices. The Company’s segments include Domestic, International and Clinical & Procedural Solutions (CPS).
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Owens & Minor Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor Inc. and related companies with MarketBeat.com's FREE daily email newsletter.